4th Quarter - Report

BROWN RUDNICK LLP for HOSPIRA, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Implementation of the Biologics Price Competition and Innovation Act (BPCIA)

LobbyistCovered position, as disclosed
LISA LAYMAN SPA, Sen. Stabenow (05-07)
HENRY W MENN CoS, Sen. Bob Graham (01 - 04)

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Pharmacy PHA

Issues relating to opioid abuse and drug shortages; Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products Proposed Rule by FDA (RIN:0910-AG94)

LobbyistCovered position, as disclosed
LISA LAYMAN SPA, Sen. Stabenow (05-07)
HENRY W MENN CoS, Sen. Bob Graham (01 - 04)

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.